128 related articles for article (PubMed ID: 10752683)
1. Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter.
Chen X; Zhang D; Dennert G; Hung G; Lee AS
Breast Cancer Res Treat; 2000 Jan; 59(1):81-90. PubMed ID: 10752683
[TBL] [Abstract][Full Text] [Related]
2. Use of the glucose starvation-inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma.
Gazit G; Hung G; Chen X; Anderson WF; Lee AS
Cancer Res; 1999 Jul; 59(13):3100-6. PubMed ID: 10397251
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
Dong D; Dubeau L; Bading J; Nguyen K; Luna M; Yu H; Gazit-Bornstein G; Gordon EM; Gomer C; Hall FL; Gambhir SS; Lee AS
Hum Gene Ther; 2004 Jun; 15(6):553-61. PubMed ID: 15212714
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.
Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV
J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
[TBL] [Abstract][Full Text] [Related]
6. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
[TBL] [Abstract][Full Text] [Related]
7. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter.
Braiden V; Ohtsuru A; Kawashita Y; Miki F; Sawada T; Ito M; Cao Y; Kaneda Y; Koji T; Yamashita S
Hum Gene Ther; 2000 Dec; 11(18):2453-63. PubMed ID: 11119417
[TBL] [Abstract][Full Text] [Related]
8. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
[TBL] [Abstract][Full Text] [Related]
10. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect.
Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS
Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395
[TBL] [Abstract][Full Text] [Related]
11. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
[TBL] [Abstract][Full Text] [Related]
12. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
Shibata MA; Morimoto J; Otsuki Y
Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
[TBL] [Abstract][Full Text] [Related]
13. Targeted gene therapy of ovarian cancer using an ovarian-specific promoter.
Bao R; Selvakumaran M; Hamilton TC
Gynecol Oncol; 2002 Feb; 84(2):228-34. PubMed ID: 11812079
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V).
Pavlovic J; Nawrath M; Tu R; Heinicke T; Moelling K
Gene Ther; 1996 Jul; 3(7):635-43. PubMed ID: 8818652
[TBL] [Abstract][Full Text] [Related]
15. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.
Vile RG; Nelson JA; Castleden S; Chong H; Hart IR
Cancer Res; 1994 Dec; 54(23):6228-34. PubMed ID: 7954471
[TBL] [Abstract][Full Text] [Related]
16. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
Hu WX; Zeng ZJ; Luo SQ; Chen Q
Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
[TBL] [Abstract][Full Text] [Related]
17. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
19. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
Walling HW; Swarthout JT; Culver KW
Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
[TBL] [Abstract][Full Text] [Related]
20. Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter.
Luo EW; Liao ML; Chien CL
PLoS One; 2021; 16(8):e0253008. PubMed ID: 34370752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
